Chapter 19 - The Company Settlement

Arden Clinical Systems settled civil claims involving Cresswell.
Cresswell repaid $1.28 million covering unsupported charges, interest, and negotiated adjustments.
Celeste forfeited certain deferred compensation.
Corporate governance changed:
No related-party vendor without audit committee approval.
Direct beneficial ownership disclosure.
Independent valuation for major transactions.
Trust voting separated from executive management.
Whistleblower reporting outside family channels.
Employee board representation increased.
The company later accepted a minority investment rather than a sale.
$48 million for twenty-four percent.
Enough capital to expand.
No control transfer.
Independent investor.
No Celeste advisory fee.
Less dramatic.
May you like
Healthier.
---